These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27143462)

  • 1. [Drug use in blood donors].
    Berg JA; Schjøtt J
    Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety.
    Teo D
    Biologicals; 2012 May; 40(3):169. PubMed ID: 22507451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood safety in Mexico. Achievements and challenges].
    Sánchez-Guerrero SA
    Rev Invest Clin; 2011; 63(3):309-13. PubMed ID: 21888294
    [No Abstract]   [Full Text] [Related]  

  • 5. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood transfusion and supply chain management safety].
    Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
    Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of medication taken by blood donors in plasma for transfusion.
    van Tilborgh-de Jong AJ; Wiersum-Osselton JC; Touw DJ; Schipperus MR
    Vox Sang; 2015 May; 108(4):323-7. PubMed ID: 25557151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ensuring the safety of donated blood].
    Danic B
    Rev Infirm; 2012 Jan; (177):18-20. PubMed ID: 22372105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.
    O'Brien SF; Delage G; Seed CR; Pillonel J; Fabra CC; Davison K; Kitchen A; Steele WR; Leiby DA
    Transfus Med Rev; 2015 Jul; 29(3):162-71. PubMed ID: 25933591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood transfusion - safety of the inventory].
    Tissot JD; Danic B; Schneider T
    Presse Med; 2015 Feb; 44(2):178-88. PubMed ID: 25592756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Donation and COVID-19: Reconsidering the 3-Month Deferral Policy for Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men.
    Park C; Gellman C; O'Brien M; Eidelberg A; Subudhi I; Gorodetsky EF; Asriel B; Furlow A; Mullen M; Nadkarni G; Somani S; Sigel K; Reich DL
    Am J Public Health; 2021 Feb; 111(2):247-252. PubMed ID: 33211588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 13. Availability and safety of blood transfusion in low- and middle-income countries.
    Smit Sibinga CT; Abdella YE
    Transfusion; 2019 Jun; 59(6):2155-2157. PubMed ID: 30811600
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood safety policy: should cautionary policies be adopted with caution?
    Riva L; Petrini C
    Blood Transfus; 2018 Sep; 16(5):405-407. PubMed ID: 30183614
    [No Abstract]   [Full Text] [Related]  

  • 15. Level of hyperlipidemia in blood donors: A correlative study in North Indian population.
    Fatima N; Chandra T; Ali Mahdi A; Agarwal D
    Diabetes Metab Syndr; 2019; 13(3):2033-2036. PubMed ID: 31235132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virologic safety of donor blood after NAT testing].
    Harritshøj LH; Erikstrup C; Ullum H
    Ugeskr Laeger; 2012 Mar; 174(12):796. PubMed ID: 22433553
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
    Balint B; Vucetic D; Todorovic-Balint M; Borovcanin N; Jovanovic-Cupic S; Mandusic V
    Transfus Apher Sci; 2013 Aug; 49(1):103-4. PubMed ID: 23820432
    [No Abstract]   [Full Text] [Related]  

  • 18. How do I get an emergency civilian walking blood bank running?
    Kaada SH; Apelseth TO; Hagen KG; Kristoffersen EK; Gjerde S; Sønstabø K; Halvorsen H; Hervig T; Sunde GA; Dahle GO; Johnsen MC; Strandenes G
    Transfusion; 2019 Apr; 59(S2):1446-1452. PubMed ID: 30980744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans people and blood donation.
    Goldman M; Butler-Foster T; Lapierre D; O'Brien SF; Devor A
    Transfusion; 2020 May; 60(5):1084-1092. PubMed ID: 32343438
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of national blood safety profile: effect of contract fractionation of plasma in resource limited countries, the Moroccan experience.
    Boulahdid S; Benahadi A; Adouani B; Laouina A; Mehdaoui FE; Mokhtari A; Soulaymani A; Hajjout K; Alami R
    Haemophilia; 2014 Sep; 20(5):e359-62. PubMed ID: 25039933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.